AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 13 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 6.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $86,826,000 | -2.7% | 117,737,000 | 0.0% | 88.73% | +3.2% |
| Q4 2018 | $89,214,000 | -7.8% | 117,737,000 | -11.7% | 85.94% | +11.1% |
| Q3 2018 | $96,801,000 | +54.7% | 133,337,000 | +40.3% | 77.33% | +14.3% |
| Q2 2018 | $62,588,000 | -14.9% | 95,045,000 | 0.0% | 67.68% | +50.2% |
| Q1 2018 | $73,570,000 | -5.1% | 95,045,000 | 0.0% | 45.05% | -1.8% |
| Q4 2017 | $77,523,000 | – | 95,045,000 | – | 45.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 11,500,000 | $7,633,000 | 2.59% |
| Context Capital Management, LLC | 1,250,000 | $836,000 | 1.30% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 101,000,000 | $67,040,000 | 0.52% |
| ZAZOVE ASSOCIATES LLC | 15,070,000 | $10,125,000 | 0.48% |
| Verition Fund Management LLC | 3,500,000 | $2,341,000 | 0.45% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,934,000 | $17,270,000 | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000,000 | $664,000 | 0.32% |
| Tekla Capital Management LLC | 13,000,000 | $8,629,000 | 0.31% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,000,000 | $17,312,000,000 | 0.29% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $996,000 | 0.22% |